Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 134

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 134
---
,252 |   |     |                         | 10,226 |   |     |      |     47 |   |
| Net (decrease) increase in cash and equivalents                |     |                            |   (916 | ) |     |      |  2,391 |   |     |                         |  3,135 |   |     |      | (7,221 | ) |

Operating Activities

The following table presents
a summary of the cash used in operations as of the six months ended June 30, 2024 and 2023 and years ended December 31, 2023 and 2022:

|                                                                        |     | Six Months Ended June 30,  
 2024                       |        |   |     | 2023 |        |   |     | Year Ended      
 December 31,    
 2023            |        |   |     | 2022 |        |   |
|:-----------------------------------------------------------------------|:----|:---------------------------|:-------|:--|:----|:-----|-------:|:--|:----|:----------------|:-------|:--|:----|:-----|-------:|:--|
|                                                                        |     | -£ in thousands; unaudited |        |   |     |      |        |   |     | -£ in thousands |        |   |     |      |        |   |
| Cash flows from operating activities before changes in working capital |     |                            | (3,935 | ) |     |      | (4,086 | ) |     |                 | (7,622 | ) |     |      | (8,246 | ) |
| Changes in working capital                                             |     |                            | (872   | ) |     |      |    205 |   |     |                 | (49    | ) |     |      |    520 |   |
| Cash used in operations                                                |     |                            | (4,807 | ) |     |      | (3,881 | ) |     |                 | (7,671 | ) |     |      | (7,726 | ) |

Cash flows from Operating Activities before Changes in Working Capital. Net cash outflow from operating activities before changes in working capital was £3.94
million in the first six months of 2024, as opposed to £4.09 million during the same period in 2023. The decreased cash outflow
of £0